Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity

Sandra Voringer1, Laura Schreyer1,2, Wiebke Nadolni1

  • 1Walther-Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Munich, Germany.

Oncogene
|December 18, 2019
PubMed

Insights

Researchers found that blocking the TRPM7 channel inhibits hepatocellular carcinoma (HCC) growth by preventing MRTF-A from entering the nucleus. This TRPM7/MRTF pathway offers a new therapeutic strategy for HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Myocardin-related transcription factors (MRTFs) and Serum Response Factor (SRF) regulate genes crucial for cell functions.
  • Aberrant MRTF/SRF activity is implicated in hepatocellular carcinoma (HCC) progression.
  • MRTF-A nuclear localization is essential for its oncogenic role in HCC.

Purpose of the Study:

  • To identify compounds inhibiting MRTF-A nuclear localization and transcriptional activity.
  • To investigate the role of TRPM7 in MRTF-mediated gene expression and HCC tumorigenesis.
  • To explore TRPM7 inhibition as a potential therapeutic strategy for HCC.

Main Methods:

  • Drug screening to identify inhibitors of MRTF-A nuclear localization.
  • Pharmacological inhibition and genome editing of TRPM7.
  • Analysis of RhoA activity, actin polymerization, and MRTF-A/SRF target gene expression.
  • In vitro and in vivo assessment of TRPM7 blockade effects on HCC cells and xenografts.

Main Results:

  • NS8593, a TRPM7 inhibitor, was identified as an MRTF-A nuclear export modulator.
  • TRPM7 regulates RhoA activity, actin polymerization, and MRTF-A/SRF transcriptional activity.
  • TRPM7 signaling involves Mg2+ influx and RhoA phosphorylation by its intrinsic kinase domain.
  • TRPM7 blockade induced oncogene-induced senescence in HCC cells and xenografts.

Conclusions:

  • TRPM7 plays a critical role in regulating MRTF-A activity and HCC growth.
  • TRPM7 inhibition effectively suppresses HCC progression both in vitro and in vivo.
  • The TRPM7/MRTF axis represents a novel and promising therapeutic target for hepatocellular carcinoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.8K